OVERVIEW
Only leading formula to have both expert-recommended DHA and an exclusive HuMO6* immune blend
Has Omega 3 DHA that global experts recommend, as well as essential nutrients.
Only Enfamil NeuroPro infant has an exclusive HuMO6 immune blend, which includes 2'FL-HMO, PDX, GOS, Vitamins C&E and Selenium.
Each of these ingredients are shown to help support a baby's immune system.
Enfamil NeuroPro has naturally occurring MFGM components.**
*2-FL HMO, DPX, GOS, Vitamins C & E and Selenium.
**From whey protein concentrate composed of fats and proteins.
Your baby is full of wonder.
For that very reason, Enfamil NeuroPro includes nutrition to fuel baby's mind & body.
Omega-3 DHA like that found in Enfamil has been clinically shown to:
*Studies compared Enfamil with DHA compared to the discontinued Enfamil without DHA
Top Reasons to Choose Enfamil NeuroPro
 |
 |
|
|---|---|---|
| Global expert recommended Omega 3 DHA*. |  17mg/100 Cal |
 |
| Exclusive HuMO6 Immune Blend 2'FL-HMO, PDX, GOS, Vitamins C & E and Selenium |
|
|
| #1 Pediatrician Recommended Brand. |
|
|
Enfamil has not been shown superior to Similac in supporting brain development and immune health.
* World Health Organization recommended amount of DHA is 0.2%-0.36% of total fatty acids. Enfamil has 0.32% of total fatty acids as DHA, similar to the average amount found in world-wide mature breast milk.
* World Health Organization recommended amount of DHA is 0.2%-0.36% of total fatty acids. Enfamil has 0.32% of total fatty acids as DHA, similar to the average amount found in world-wide mature breast milk.
1. Colombo J, Carlson SE, Cheatham CL, Fitzgerald-Gustafson KM, Kepler A, Doty T. Long-chain polyunsaturated fatty acid supplementation in infancy reduces heart rate and positively affects distribution of attention. Pediatr Res. 2001;70(4):406-410.2. Drover J, Hoffman DR, Castañeda YS, Morale SE, Birch EE. Three randomized controlled trials of early long-chain polyunsaturated fatty acid supplementation on means-end problem solving in 9-month-olds. Child Dev. 2009;80(5):1376-1384. 3. Morale SE, Hoffman DR, Castañeda YS, Wheaton DH, Burns RA, Birch EE. Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev. 2005;81(2):197-203. 4. Birch EE, Garfield S, Hoffman DR, Uauy R, BIrch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42(3):174-181. 5. Colombo J, Carson SE, Cheatham CL, et al. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr. 2013;98(2):403-412.